Global Alpha-1 Antitrypsin Drugs Market Insights and Forecast to 2031

Report ID: 1450868 | Published Date: Jan 2025 | No. of Page: 93 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Alpha-1 Antitrypsin Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Parenteral
        1.2.3 Inhalation
    1.3 Market by Application
        1.3.1 Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Drugstore
        1.3.3 Hospital
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Alpha-1 Antitrypsin Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Alpha-1 Antitrypsin Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Alpha-1 Antitrypsin Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Alpha-1 Antitrypsin Drugs Sales by Region
        2.4.1 Global Alpha-1 Antitrypsin Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Alpha-1 Antitrypsin Drugs by Region (2023-2028)
    2.5 Global Alpha-1 Antitrypsin Drugs Revenue by Region
        2.5.1 Global Alpha-1 Antitrypsin Drugs Revenue by Region (2017-2022)
        2.5.2 Global Alpha-1 Antitrypsin Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Alpha-1 Antitrypsin Drugs Sales by Manufacturers
        3.1.1 Global Top Alpha-1 Antitrypsin Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Alpha-1 Antitrypsin Drugs in 2021
    3.2 Global Alpha-1 Antitrypsin Drugs Revenue by Manufacturers
        3.2.1 Global Alpha-1 Antitrypsin Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Alpha-1 Antitrypsin Drugs Revenue in 2021
    3.3 Global Alpha-1 Antitrypsin Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Alpha-1 Antitrypsin Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Alpha-1 Antitrypsin Drugs Sales by Type
        4.1.1 Global Alpha-1 Antitrypsin Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Alpha-1 Antitrypsin Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Alpha-1 Antitrypsin Drugs Revenue by Type
        4.2.1 Global Alpha-1 Antitrypsin Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Alpha-1 Antitrypsin Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Alpha-1 Antitrypsin Drugs Price by Type
        4.3.1 Global Alpha-1 Antitrypsin Drugs Price by Type (2017-2022)
        4.3.2 Global Alpha-1 Antitrypsin Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Alpha-1 Antitrypsin Drugs Sales by Application
        5.1.1 Global Alpha-1 Antitrypsin Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Alpha-1 Antitrypsin Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Alpha-1 Antitrypsin Drugs Revenue by Application
        5.2.1 Global Alpha-1 Antitrypsin Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Alpha-1 Antitrypsin Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Alpha-1 Antitrypsin Drugs Price by Application
        5.3.1 Global Alpha-1 Antitrypsin Drugs Price by Application (2017-2022)
        5.3.2 Global Alpha-1 Antitrypsin Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Alpha-1 Antitrypsin Drugs Market Size by Type
        6.1.1 North America Alpha-1 Antitrypsin Drugs Sales by Type (2017-2028)
        6.1.2 North America Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2028)
    6.2 North America Alpha-1 Antitrypsin Drugs Market Size by Application
        6.2.1 North America Alpha-1 Antitrypsin Drugs Sales by Application (2017-2028)
        6.2.2 North America Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2028)
    6.3 North America Alpha-1 Antitrypsin Drugs Market Size by Country
        6.3.1 North America Alpha-1 Antitrypsin Drugs Sales by Country (2017-2028)
        6.3.2 North America Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Alpha-1 Antitrypsin Drugs Market Size by Type
        7.1.1 Europe Alpha-1 Antitrypsin Drugs Sales by Type (2017-2028)
        7.1.2 Europe Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2028)
    7.2 Europe Alpha-1 Antitrypsin Drugs Market Size by Application
        7.2.1 Europe Alpha-1 Antitrypsin Drugs Sales by Application (2017-2028)
        7.2.2 Europe Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2028)
    7.3 Europe Alpha-1 Antitrypsin Drugs Market Size by Country
        7.3.1 Europe Alpha-1 Antitrypsin Drugs Sales by Country (2017-2028)
        7.3.2 Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Alpha-1 Antitrypsin Drugs Market Size by Type
        8.1.1 Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Alpha-1 Antitrypsin Drugs Market Size by Application
        8.2.1 Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Alpha-1 Antitrypsin Drugs Market Size by Region
        8.3.1 Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Alpha-1 Antitrypsin Drugs Market Size by Type
        9.1.1 Latin America Alpha-1 Antitrypsin Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2028)
    9.2 Latin America Alpha-1 Antitrypsin Drugs Market Size by Application
        9.2.1 Latin America Alpha-1 Antitrypsin Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2028)
    9.3 Latin America Alpha-1 Antitrypsin Drugs Market Size by Country
        9.3.1 Latin America Alpha-1 Antitrypsin Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size by Type
        10.1.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size by Application
        10.2.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size by Country
        10.3.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Baxter
        11.1.1 Baxter Corporation Information
        11.1.2 Baxter Overview
        11.1.3 Baxter Alpha-1 Antitrypsin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Baxter Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Baxter Recent Developments
    11.2 CSL Behring
        11.2.1 CSL Behring Corporation Information
        11.2.2 CSL Behring Overview
        11.2.3 CSL Behring Alpha-1 Antitrypsin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 CSL Behring Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 CSL Behring Recent Developments
    11.3 Grifols
        11.3.1 Grifols Corporation Information
        11.3.2 Grifols Overview
        11.3.3 Grifols Alpha-1 Antitrypsin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Grifols Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Grifols Recent Developments
    11.4 Kamada
        11.4.1 Kamada Corporation Information
        11.4.2 Kamada Overview
        11.4.3 Kamada Alpha-1 Antitrypsin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Kamada Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Kamada Recent Developments
    11.5 Abeona Therapeutics
        11.5.1 Abeona Therapeutics Corporation Information
        11.5.2 Abeona Therapeutics Overview
        11.5.3 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Abeona Therapeutics Recent Developments
    11.6 Alnylam Pharmaceuticals
        11.6.1 Alnylam Pharmaceuticals Corporation Information
        11.6.2 Alnylam Pharmaceuticals Overview
        11.6.3 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Alnylam Pharmaceuticals Recent Developments
    11.7 Applied Genetic Technologies Corp
        11.7.1 Applied Genetic Technologies Corp Corporation Information
        11.7.2 Applied Genetic Technologies Corp Overview
        11.7.3 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Applied Genetic Technologies Corp Recent Developments
    11.8 Arrowhead Research Corporation
        11.8.1 Arrowhead Research Corporation Corporation Information
        11.8.2 Arrowhead Research Corporation Overview
        11.8.3 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Arrowhead Research Corporation Recent Developments
    11.9 Baxalta
        11.9.1 Baxalta Corporation Information
        11.9.2 Baxalta Overview
        11.9.3 Baxalta Alpha-1 Antitrypsin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Baxalta Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Baxalta Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Alpha-1 Antitrypsin Drugs Industry Chain Analysis
    12.2 Alpha-1 Antitrypsin Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Alpha-1 Antitrypsin Drugs Production Mode & Process
    12.4 Alpha-1 Antitrypsin Drugs Sales and Marketing
        12.4.1 Alpha-1 Antitrypsin Drugs Sales Channels
        12.4.2 Alpha-1 Antitrypsin Drugs Distributors
    12.5 Alpha-1 Antitrypsin Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Alpha-1 Antitrypsin Drugs Industry Trends
    13.2 Alpha-1 Antitrypsin Drugs Market Drivers
    13.3 Alpha-1 Antitrypsin Drugs Market Challenges
    13.4 Alpha-1 Antitrypsin Drugs Market Restraints
14 Key Findings in The Global Alpha-1 Antitrypsin Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Parenteral
    Table 3. Major Manufacturers of Inhalation
    Table 4. Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Alpha-1 Antitrypsin Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Alpha-1 Antitrypsin Drugs Sales by Region (2017-2022) & (K Units)
    Table 7. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2017-2022)
    Table 8. Global Alpha-1 Antitrypsin Drugs Sales by Region (2023-2028) & (K Units)
    Table 9. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2023-2028)
    Table 10. Global Alpha-1 Antitrypsin Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2017-2022)
    Table 12. Global Alpha-1 Antitrypsin Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2023-2028)
    Table 14. Global Alpha-1 Antitrypsin Drugs Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Alpha-1 Antitrypsin Drugs Sales Share by Manufacturers (2017-2022)
    Table 16. Global Alpha-1 Antitrypsin Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Alpha-1 Antitrypsin Drugs Revenue Share by Manufacturers (2017-2022)
    Table 18. Alpha-1 Antitrypsin Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Alpha-1 Antitrypsin Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Alpha-1 Antitrypsin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Antitrypsin Drugs as of 2021)
    Table 21. Alpha-1 Antitrypsin Drugs Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Alpha-1 Antitrypsin Drugs Product Offered
    Table 23. Date of Manufacturers Enter into Alpha-1 Antitrypsin Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
    Table 26. Global Alpha-1 Antitrypsin Drugs Sales by Type (2023-2028) & (K Units)
    Table 27. Global Alpha-1 Antitrypsin Drugs Sales Share by Type (2017-2022)
    Table 28. Global Alpha-1 Antitrypsin Drugs Sales Share by Type (2023-2028)
    Table 29. Global Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Alpha-1 Antitrypsin Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Alpha-1 Antitrypsin Drugs Revenue Share by Type (2017-2022)
    Table 32. Global Alpha-1 Antitrypsin Drugs Revenue Share by Type (2023-2028)
    Table 33. Alpha-1 Antitrypsin Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Alpha-1 Antitrypsin Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
    Table 36. Global Alpha-1 Antitrypsin Drugs Sales by Application (2023-2028) & (K Units)
    Table 37. Global Alpha-1 Antitrypsin Drugs Sales Share by Application (2017-2022)
    Table 38. Global Alpha-1 Antitrypsin Drugs Sales Share by Application (2023-2028)
    Table 39. Global Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Alpha-1 Antitrypsin Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Alpha-1 Antitrypsin Drugs Revenue Share by Application (2017-2022)
    Table 42. Global Alpha-1 Antitrypsin Drugs Revenue Share by Application (2023-2028)
    Table 43. Alpha-1 Antitrypsin Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Alpha-1 Antitrypsin Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
    Table 46. North America Alpha-1 Antitrypsin Drugs Sales by Type (2023-2028) & (K Units)
    Table 47. North America Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Alpha-1 Antitrypsin Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
    Table 50. North America Alpha-1 Antitrypsin Drugs Sales by Application (2023-2028) & (K Units)
    Table 51. North America Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Alpha-1 Antitrypsin Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Alpha-1 Antitrypsin Drugs Sales by Country (2017-2022) & (K Units)
    Table 54. North America Alpha-1 Antitrypsin Drugs Sales by Country (2023-2028) & (K Units)
    Table 55. North America Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Alpha-1 Antitrypsin Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Alpha-1 Antitrypsin Drugs Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Alpha-1 Antitrypsin Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Alpha-1 Antitrypsin Drugs Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Alpha-1 Antitrypsin Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Alpha-1 Antitrypsin Drugs Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Alpha-1 Antitrypsin Drugs Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Alpha-1 Antitrypsin Drugs Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Alpha-1 Antitrypsin Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Alpha-1 Antitrypsin Drugs Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Alpha-1 Antitrypsin Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Alpha-1 Antitrypsin Drugs Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Alpha-1 Antitrypsin Drugs Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Alpha-1 Antitrypsin Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Baxter Corporation Information
    Table 106. Baxter Description and Major Businesses
    Table 107. Baxter Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. Baxter Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Baxter Recent Developments
    Table 110. CSL Behring Corporation Information
    Table 111. CSL Behring Description and Major Businesses
    Table 112. CSL Behring Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. CSL Behring Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. CSL Behring Recent Developments
    Table 115. Grifols Corporation Information
    Table 116. Grifols Description and Major Businesses
    Table 117. Grifols Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Grifols Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Grifols Recent Developments
    Table 120. Kamada Corporation Information
    Table 121. Kamada Description and Major Businesses
    Table 122. Kamada Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Kamada Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Kamada Recent Developments
    Table 125. Abeona Therapeutics Corporation Information
    Table 126. Abeona Therapeutics Description and Major Businesses
    Table 127. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Abeona Therapeutics Recent Developments
    Table 130. Alnylam Pharmaceuticals Corporation Information
    Table 131. Alnylam Pharmaceuticals Description and Major Businesses
    Table 132. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Alnylam Pharmaceuticals Recent Developments
    Table 135. Applied Genetic Technologies Corp Corporation Information
    Table 136. Applied Genetic Technologies Corp Description and Major Businesses
    Table 137. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 138. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Applied Genetic Technologies Corp Recent Developments
    Table 140. Arrowhead Research Corporation Corporation Information
    Table 141. Arrowhead Research Corporation Description and Major Businesses
    Table 142. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 143. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Arrowhead Research Corporation Recent Developments
    Table 145. Baxalta Corporation Information
    Table 146. Baxalta Description and Major Businesses
    Table 147. Baxalta Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 148. Baxalta Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Baxalta Recent Developments
    Table 150. Key Raw Materials Lists
    Table 151. Raw Materials Key Suppliers Lists
    Table 152. Alpha-1 Antitrypsin Drugs Distributors List
    Table 153. Alpha-1 Antitrypsin Drugs Customers List
    Table 154. Alpha-1 Antitrypsin Drugs Market Trends
    Table 155. Alpha-1 Antitrypsin Drugs Market Drivers
    Table 156. Alpha-1 Antitrypsin Drugs Market Challenges
    Table 157. Alpha-1 Antitrypsin Drugs Market Restraints
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Alpha-1 Antitrypsin Drugs Product Picture
    Figure 3. Global Alpha-1 Antitrypsin Drugs Market Share by Type in 2021 & 2028
    Figure 3. Parenteral Product Picture
    Figure 4. Inhalation Product Picture
    Figure 5. Global Alpha-1 Antitrypsin Drugs Market Share by Application in 2021 & 2028
    Figure 6. Drugstore
    Figure 7. Hospital
    Figure 8. Others
    Figure 9. Alpha-1 Antitrypsin Drugs Report Years Considered
    Figure 10. Global Alpha-1 Antitrypsin Drugs Sales 2017-2028 (K Units)
    Figure 11. Global Alpha-1 Antitrypsin Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Alpha-1 Antitrypsin Drugs Revenue 2017-2028 (US$ Million)
    Figure 13. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2017-2022)
    Figure 15. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2023-2028)
    Figure 16. North America Alpha-1 Antitrypsin Drugs Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Alpha-1 Antitrypsin Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Alpha-1 Antitrypsin Drugs Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Alpha-1 Antitrypsin Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Alpha-1 Antitrypsin Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Alpha-1 Antitrypsin Drugs Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Alpha-1 Antitrypsin Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Alpha-1 Antitrypsin Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Alpha-1 Antitrypsin Drugs in the World: Market Share by Alpha-1 Antitrypsin Drugs Revenue in 2021
    Figure 28. Global Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2028)
    Figure 30. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2017-2028)
    Figure 31. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2028)
    Figure 32. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2017-2028)
    Figure 33. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2028)
    Figure 34. North America Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2017-2028)
    Figure 35. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2028)
    Figure 36. North America Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2017-2028)
    Figure 37. North America Alpha-1 Antitrypsin Drugs Sales Share by Country (2017-2028)
    Figure 38. North America Alpha-1 Antitrypsin Drugs Revenue Share by Country (2017-2028)
    Figure 39. U.S. Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2028)
    Figure 42. Europe Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2028)
    Figure 44. Europe Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Alpha-1 Antitrypsin Drugs Sales Share by Country (2017-2028)
    Figure 46. Europe Alpha-1 Antitrypsin Drugs Revenue Share by Country (2017-2028)
    Figure 47. Germany Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 48. France Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue Share by Region (2017-2028)
    Figure 58. China Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 61. India Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Alpha-1 Antitrypsin Drugs Sales Share by Country (2017-2028)
    Figure 73. Latin America Alpha-1 Antitrypsin Drugs Revenue Share by Country (2017-2028)
    Figure 74. Mexico Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue Share by Country (2017-2028)
    Figure 83. Turkey Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
    Figure 86. Alpha-1 Antitrypsin Drugs Value Chain
    Figure 87. Alpha-1 Antitrypsin Drugs Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Baxter
CSL Behring
Grifols
Kamada
Abeona Therapeutics
Alnylam Pharmaceuticals
Applied Genetic Technologies Corp
Arrowhead Research Corporation
Baxalta
Frequently Asked Questions
Alpha-1 Antitrypsin Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Alpha-1 Antitrypsin Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Alpha-1 Antitrypsin Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Dental Services

Dental Services market is segmented by players, region (country), by Type and by Application. Pla ... Read More